Search

Search Constraints

You searched for: Author/Creator Caillot, Denis

Search Results

1. Azacitidine for the treatment of relapsed and refractory AML in older patients. Issue 2 (February 2015)

2. Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study. Issue 10192 (6th July 2019)

3. Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia. Issue 7 (8th July 2022)

4. Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study. Issue 2 (1st January 2023)

5. Early achievement of measurable residual disease negativity in the treatment of multiple myeloma as predictor of outcome. (11th March 2022)

6. Evaluation of Serum Mucorales Polymerase Chain Reaction (PCR) for the Diagnosis of Mucormycoses: The MODIMUCOR Prospective Trial . (5th January 2022)

7. Evolution of procalcitonin, C‐reactive protein and fibrinogen levels in neutropenic leukaemia patients with invasive pulmonary aspergillosis or mucormycosis. Issue 6 (2nd March 2016)

8. Health-related quality of life results from the IFM 2009 trial: treatment with lenalidomide, bortezomib, and dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma. Issue 6 (11th May 2020)

9. Heavy + light chain analysis to assign myeloma response is analogous to the IMWG response criteria. Issue 3 (4th March 2018)

10. High‐dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL‐GITMO. (9th July 2018)